What is required for returning a C11 medication?

To return a C11 medication, it is required that a DEA 222 form or its electronic equivalent be completed. This requirement is in place due to the strict regulations surrounding controlled substances, which are monitored by the Drug Enforcement Administration (DEA) to prevent misuse and diversion.

The DEA 222 form is a formal way to document the transfer of controlled substances between registrants, ensuring that all transactions are accounted for, which is crucial for maintaining accurate records and compliance with federal laws. This form allows the pharmacy to outline specific details about the medication being returned, including the quantity and type of drug.

Understanding this requirement helps pharmacy technicians manage controlled substances properly, ensuring that they comply with legal regulations while also safeguarding public health. The other options do not reflect the regulatory requirements set forth by the DEA for the return of C11 medications.